MYX mayne pharma group limited

Ann: MAYNE PHARMA provides FDA update on generic NUVARING, page-6

  1. 4,602 Posts.
    lightbulb Created with Sketch. 3300
    Actually, re-reading this press release enrages me. They are spinning this like it’s a positive: “...one step closer to approval”. Even just a regular small time investor in US pharma/biotech knows that receipt of a CRL from the FDA is the worst possible outcome. A CRL is a formal decision not a step in the process, and Scott well knows this. Most stocks get absolutely smashed after a CRL - in recent months I’ve seen anywhere from 50-80% plunges in the share price within minutes of news that a CRL has been issued. For many drug companies it’s the end of the road for that drug.

    What planet is Mayne on here? I like optimism but I don’t appreciate bullish!t dressed up as tinsel.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.23
Change
-0.020(0.38%)
Mkt cap ! $430.6M
Open High Low Value Volume
$5.25 $5.30 $5.23 $369.2K 69.89K

Buyers (Bids)

No. Vol. Price($)
2 1300 $5.22
 

Sellers (Offers)

Price($) Vol. No.
$5.25 2070 10
View Market Depth
Last trade - 11.15am 28/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.